For US and Canadian Stocks, the Overview page includes key statistics on the stock’s fundamentals, with a link to see more. Provides a general description of the business conducted by this company. Barchart is committed to ensuring digital accessibility for individuals with disabilities. We are continuously working to improve our web experience, and encourage users to Contact Us for feedback and accommodation requests. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Pulmatrix’s stock is owned by a number of retail and institutional investors.

SectorIndustryMarket CapRevenue MedicalMedical – Biomedical and Genetics$0.014B$0.005B Pulmatrix, Inc. is a biopharmaceutical company which is engaged in developing inhaled therapies for serious pulmonary disease. The Company’s proprietary product pipeline includes PUR1900, an inhaled anti-fungal for cystic fibrosis, PUR0200, a branded generic for chronic obstructive pulmonary disease which are in different clinical stage. Pulmatrix, Inc., formerly known as Ruthigen, Inc., is based in Lexington, MA.

Pulmatrix, Inc. doesn’t possess the right combination of the two key Forex Order Types ingredients for a likely earnings beat in its upcoming report.

Pulmatrix Inc. is a clinical stage biotechnology company, which engages in the discovery and development of novel inhaled therapeutic products for respiratory and other diseases. It offers products based on its proprietary dry powder delivery technology, iSPERSE, which enables… Test Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the discovery and development of novel inhaled therapeutic products for respiratory and other diseases. It offers products based on its proprietary dry powder delivery technology, iSPERSE, which enables deli… Pulmatrix, Inc. is a clinical-stage biotechnology company, which is focused on the discovery and development of inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs.

Gurus may be added or dropped from the GuruFocus site at any time. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.

Pulmatrix, Inc. (PULM) Reports Q2 Loss, Tops Revenue Estimates

Verify your identity, personalize the content you receive, or create and administer your account. Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have 4xCube Forex Broker Overview unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data. Information is provided ‘as-is’ and solely for informational purposes and is not advice.

• All investments involve risk, and not all risks are suitable for every investor.
• This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 to -2 .
• The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations.
• Sign Up NowGet this delivered to your inbox, and more info about our products and services.

There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The Barchart Technical Opinion widget shows you today’s overally Barchart Opinion with general information on how to interpret the short and longer term signals.

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. Shares of Pulmatrix Inc. more than doubled Monday, rocketing 124% on heavy volume, after the company said it entered into a “binding term sheet” with Cipla Ltd. subsidiary Cipla Technologies LLC for the development and co… The historical news coverage of this asset in the last three months. My partner and I predict this stock is going to spike exponentially by Friday next week. Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index quotes are real-time.

Pulmatrix, Inc. (PULM) Reports Q3 Loss, Misses Revenue Estimates

MarketBeat has tracked 4 news articles for Pulmatrix this week, compared to 1 article on an average week. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. See how Bullish or Bearish a stock is based on its recent media coverage.

Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive. We’d like to share more about how we work and what drives our day-to-day business. Webull Financial LLC is a member of SIPC, which protects securities customers of its members up to $500,000 (including $250,000 for claims for cash).

Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer. Pulmatrix has a short interest ratio (“days to cover”) of 0.6, which is generally considered an acceptable ratio of short interest to trading volume. According to analysts’ consensus price target of $10.00, Pulmatrix has a forecasted upside of 161.8% from its current price of $3.82.

Health Care Stocks Moving In Wednesday’s After-Market Session

Webull Financial LLC is a member of the Financial Industry Regulatory Authority , Securities Investor Protection Corporation , The New York Stock Exchange , NASDAQ and Cboe EDGX Exchange, Inc . Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.

All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends. Cryptocurrency execution and custody services are provided by Apex Crypto LLC through a software licensing agreement between Apex Crypto LLC and Webull Pay LLC. Cryptocurrency trading is offered through an account with Apex Crypto. Apex Crypto is not a registered broker-dealer or FINRA member and your cryptocurrency holdings are not FDIC or SIPC insured. Please ensure that you fully understand the risks involved before trading.

PULM Related stocks

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more. Highlights important summary options statistics to provide a forward looking indication of investors’ sentiment. The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction. Sign-up to receive the latest news and ratings for Pulmatrix and its competitors with MarketBeat’s FREE daily newsletter. High institutional ownership can be a signal of strong market trust in this company.

No offer to buy securities can be accepted, and no part of the purchase price can be received, until an offering statement filed with the SEC has been qualified by the SEC. An indication of interest to purchase securities involves no obligation or commitment of any kind. Free trading of stocks, ETFs, and options refers to $0 commissions for SpreadEx Broker Review Webull Financial LLC self-directed individual cash or margin brokerage accounts and IRAs that trade U.S. listed securities via mobile devices, desktop or website products. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.